Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

Osman Öcal; Christoph Johannes Zech; Maria Antonietta Bali; David Pasquier; Felix Mottaghy; Ingo Einspieler; Nikolaos Kartalis; Irene Bargellini; Roberto Iezzi; Timm Denecke; Wolfgang Gerhard Kunz; Bernhard Gebauer; Henning Wege; Roberto Cannella; Daniela Elena Oprea-Lager; Arndt Vogel; Bruno Sangro; Max Seidensticker

doi:10.1007/s00330-025-12045-7

. 2025 Oct 31;36(4):3331–3332. doi: 10.1007/s00330-025-12045-7

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

Osman Öcal ^1,^2,^✉, Christoph Johannes Zech ^3,⁴, Maria Antonietta Bali ^4,⁵, David Pasquier ^2,^6,⁷, Felix Mottaghy ^8,⁹, Ingo Einspieler ¹⁰, Nikolaos Kartalis ^4,¹¹, Irene Bargellini ¹², Roberto Iezzi ^13,¹⁴, Timm Denecke ¹⁵, Wolfgang Gerhard Kunz ^2,¹⁶, Bernhard Gebauer ¹⁷, Henning Wege ¹⁸, Roberto Cannella ¹⁹, Daniela Elena Oprea-Lager ^2,²⁰, Arndt Vogel ^21,²², Bruno Sangro ²³, Max Seidensticker ^2,¹⁶, on behalf of the study group

¹Department of Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany

²Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium

³Radiology and Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland

⁴European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria

⁵Radiology Department, Institut Jules Bordet Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium

⁶Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France

⁷CRIStAL, CNRS, Lille University, Lille, France

⁸Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, The Netherlands

⁹Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany

¹⁰Department of Radiology, University Hospital Regensburg, Regensburg, Germany

¹¹Division of Radiology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden

¹²Diagnostic and Interventional Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy

¹³Dipartimento di Diagnostica per Immagini e Radioterapia Oncologica, Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC di Radiologia d’Urgenza e Interventistica, Roma, Italia

¹⁴Institute of Radiology, Catholic University, Rome, Italy

¹⁵Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany

¹⁶Department of Radiology, University Hospital, LMU Munich, Munich, Germany

¹⁷Department of Radiology, Charité—University Medicine Berlin, Berlin, Germany

¹⁸Cancer Center Esslingen, Klinikum Esslingen, Esslingen, Germany

¹⁹Section of Radiology, Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University of Palermo, Palermo, Italy

²⁰Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands

²¹Division of Gastroenterology and Hepatology, Toronto General Hospital, Toronto, ON, Canada; Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON Canada

²²Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany

²³Liver Unit and HPB Oncology Area, Clínica Universidad de Navarra and CIBEREHD, Pamplona, Spain

²⁴Sapienza University of Rome, Rome, Italy

²⁵La Fe Health Research Institute (IIS La Fe), Valencia, Spain

²⁶Bern University Hospital (Inselspital), Bern, Switzerland

²⁷Niels-Stensen-Kliniken Marienhospital, Osnabrück, Germany

²⁸Amsterdam UMC, Amsterdam, The Netherlands

²⁹Hacettepe University, Ankara, Turkey

³⁰Ospedale del Mare, Naples, Italy

³¹Maastricht University Medical Center, Maastricht, The Netherlands

³²UZ Leuven, Leuven, Belgium

³³University and Hospital Trust, Verona, Italy

³⁴Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK

³⁵University Hospital of Magdeburg, Magdeburg, Germany

³⁶Leiden University Medical Center, Leiden, The Netherlands

³⁷Ramón y Cajal University Hospital, Madrid, Spain

³⁸University Hospitals Bristol, Bristol, UK

³⁹Giresun University Hospital, Giresun, Turkey

⁴⁰San Giovanni Hospital, Bellinzona, Switzerland

⁴¹University Hospital Regensburg, Regensburg, Germany

⁴²Charité Universitätsmedizin Berlin, Berlin, Germany

⁴³Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

⁴⁴Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

⁴⁵Klinikum Würzburg Mitte, Würzburg, Germany

^✉

Corresponding author.

PMCID: PMC13035552 PMID: 41171354

Correction to: European Radiology

10.1007/s00330-025-11699-7 published online 23 May 2025.

In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy.

Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article.

Furthermore, the following Conflict of interest statement was missing in the original article:

L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks.

The original article has been corrected.

PERMALINK

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

Osman Öcal

Christoph Johannes Zech

Maria Antonietta Bali

David Pasquier

Felix Mottaghy

Ingo Einspieler

Nikolaos Kartalis

Irene Bargellini

Roberto Iezzi

Timm Denecke

Wolfgang Gerhard Kunz

Bernhard Gebauer

Henning Wege

Roberto Cannella

Daniela Elena Oprea-Lager

Arndt Vogel

Bruno Sangro

Max Seidensticker

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

Osman Öcal

Christoph Johannes Zech

Maria Antonietta Bali

David Pasquier

Felix Mottaghy

Ingo Einspieler

Nikolaos Kartalis

Irene Bargellini

Roberto Iezzi

Timm Denecke

Wolfgang Gerhard Kunz

Bernhard Gebauer

Henning Wege

Roberto Cannella

Daniela Elena Oprea-Lager

Arndt Vogel

Bruno Sangro

Max Seidensticker

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases